Harvard Bioscience
(HBIO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,806 | 2,629 | 5,882 | 8,335 | 6,845 |
| Receivables | 13,879 | 14,710 | 15,425 | 20,704 | 21,550 |
| Inventories | 22,689 | 23,181 | 23,143 | 22,061 | 23,894 |
| Other current assets | 4,146 | 3,582 | 3,715 | 2,472 | 0 |
| TOTAL | $43,520 | $44,102 | $48,165 | $53,572 | $52,289 |
| Non-Current Assets | |||||
| PPE Net | 4,309 | 4,222 | 4,488 | 4,776 | 5,234 |
| Intangibles | 91,962 | 92,453 | 93,599 | 95,786 | 96,437 |
| Other Non-Current Assets | 9,823 | 9,908 | 10,008 | 10,736 | 8,817 |
| TOTAL | $106,094 | $106,583 | $108,095 | $111,298 | $110,488 |
| Total Assets | $149,614 | $150,685 | $156,260 | $164,870 | $162,777 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,807 | 2,807 | 2,807 | 6,900 | 2,607 |
| Accounts payable and accrued liabilities | 5,990 | 6,596 | 6,625 | 5,339 | 5,266 |
| Accrued Expenses | 749 | 969 | 624 | N/A | 385 |
| Other current liabilities | 5,953 | 6,390 | 7,449 | 6,700 | 7,465 |
| TOTAL | $21,248 | $22,663 | $23,475 | $25,312 | $21,697 |
| Non-Current Liabilities | |||||
| Long Term Debt | 40,669 | 40,921 | 46,280 | 46,917 | 51,712 |
| Deferred Revenues | 3,559 | 3,652 | 3,673 | 3,949 | 3,550 |
| Other Non-Current Liabilities | 8,624 | 8,757 | 8,729 | 8,973 | 9,998 |
| TOTAL | $51,199 | $51,954 | $56,776 | $57,864 | $63,977 |
| Total Liabilities | $72,447 | $74,617 | $80,251 | $83,176 | $85,674 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 38,976 | 38,943 | 38,380 | 38,348 | 38,066 |
| Common Shares | 438 | 438 | 438 | 438 | 436 |
| Retained earnings | -131,771 | -130,673 | -129,092 | -124,576 | -125,125 |
| Other shareholders' equity | -11,642 | -13,372 | -14,077 | -12,357 | -15,385 |
| TOTAL | $77,167 | $76,068 | $76,009 | $81,694 | $77,103 |
| Total Liabilities And Equity | $149,614 | $150,685 | $156,260 | $164,870 | $162,777 |